Need Help?

Submission 70 - study_title 1

Submission 70 - description 1

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000000099 454 GS AB 3500 Genetic Analyzer MGISEQ-2000RS Sequel IIe 4
EGAD50000000100 2
Publications Citations
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
Nat Commun 15: 2024 1823
1